Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maarit H. Vuento"'
Autor:
Tuula A. Salmi, Juha I. Mäkinen, Matti Grönroos, Jouko P. Pirhonen, Maarit H. Vuento, Pekka J. Laippala
Publikováno v:
Cancer. 76:1214-1218
Background. To evaluate the prevalence and significance of abnormal ovarian findings in asymptomatic postmenopausal women, screening for ovarian cancer with color Doppler ultrasound was performed. Methods. One thousand three hundred sixty-four asympt
Publikováno v:
International Journal of Gynecological Cancer. 5:390-395
Diabetics are at high risk of developing endometrial cancer; the relative risk of endometrial cancer in diabetics is fourfold in comparison to non-diabetic controls. The purpose of this longitudinal study was to evaluate the effectiveness of screenin
Autor:
Matti Grönroos, Juhani E. Tyrkkö, E. Anneli Jalava, Maarit H. Vuento, Jouni I. Maatela, Tuula A. Salmi, Eeva R. Savolainen, Arpo R. Aromaa, Rita Siegberg, Tapani V. Kauraniemi
Publikováno v:
Cancer. 71:1279-1282
Background. The interest in mass screening programs for the early detection of endometrial cancer (EC) has grown with the rising incidence of this disease. Preliminary programs directed at asymptomatic women with only one risk factor, i.e. age, have
Publikováno v:
Biopharmaceutics & Drug Disposition. 12:113-117
Nimesulide is a non-steroidal anti-inflammatory agent which has proved to be effective in reducing menstrual discomfort in dysmenorrhoeaic women. To determine the concentrations of this drug in the uterus (fundus, cervix), oviduct, and ovaries and to
Autor:
Jouko P. Pirhonen, Juha Mäkinen, Pekka J. Laippala, Juhani E. Tyrkkö, Thula A. Salmi, Maarit H. Vuento, Matti Grönroos
Publikováno v:
British journal of obstetrics and gynaecology. 106(1)
Objective To evaluate endometrial thickness and uterine arterial flow measurement as predictors of endometrial cancer. Design Prospective study among a cohort of women invited to age-adjusted, population-based breast cancer screening by mammography.
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 106:613-613
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 68(2)
48 patients in the first trimester of pregnancy received a single oral dose of placebo or enisoprost (prostaglandin E1 analogue): 10, 25, 50, 100, 200 or 400 micrograms. Uterine activity was recorded for 1 h before and for 4 h after administration of